Mersana Therapeutics Inc.
MRSN
|
|
| |
|
| Trading Volume | 80,554 |
|
|
5.94 - 1.11 |
| Market Cap Full | $ 184.5M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -3.2% | 93.1% | -29.9% | -36.3% |
| Q2 | - | -54.9% | -20% | 15.1% |
| Q3 | - | -23.9% | -61.4% | 46.3% |
| Q4 | - | -44.1% | 84.1% | -13.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 36.2 | 72.2 | -17.7 | -27.2 | -28.4 | -14.8 | 0.8 | -23.9 | - | - | - | -37.6 |
| 2023 | |||||||||||
| 12.3 | -7.9 | -32.2 | 6.6 | 71.7 | -56.3 | -62.8 | -9.4 | 14.4 | -6.3 | 38.7 | 40.6 |
| 2022 | |||||||||||
| -24.3 | -8 | -8.5 | -13.3 | -4 | 38.3 | 9.7 | 47.9 | -9.9 | 16.3 | -15.3 | -12 |
| 2021 | |||||||||||
| -29.2 | -3.6 | -11 | -1.6 | -9 | -6.3 | -19 | 26.6 | -32.3 | -9.2 | -21.3 | -6.5 |
| 2020 | |||||||||||
| 21 | 28.3 | -32.7 | 54.9 | 150.7 | 3.4 | -15 | -3.6 | -2.8 | -3.2 | 41.4 | 4.4 |
EPS
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Q1 | -0.6 | -0.5 | -0.4 |
| Q2 | -0.6 | -0.6 | -0.3 |
| Q3 | -0.6 | -0.6 | -0.3 |
| Q4 | -0.4 | -0.7 | -0.4 |
| A | -2.2 | -2.4 | -1.4 |